Lifescience Global

Journal of Cancer Research Updates gives 'Free Access' to articles

Cancer-Research-Updates headerJanuary 16, 2013: Lifescience Global announced today that all articles in Journal of Cancer Research Updates Volume 1 Number 1 will be available with free 'Open Access' full text downloads to all its readers. This step has been taken after tremendous response of its readers and requests to view full text articles. The first issue consisted of 19 articles including clinical case reports, review articles, basic research and clinical studies. The articles were submitted from 8 countries including USA (6), Spain (3) , China (2), Japan (2), Germany (1), Poland (1), Croatia (1) Italy (1) and India (2). To read this issue click here 'or' follow the links in this article .

 
Journal of Cancer Research Updates is a peer reviewed journal which offers an exciting avenue for the dissemination of important discoveries in all areas of cancer science. The goal is to highlight the recent advances of cancer research in order to understand, treat and eradicate cancer. The journal aims to ensure open and equitable access to international multidisciplinary readership.

 

Table of Contents (Volume 1 Number 1, 2012)

 Preface

Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study - Pages 1-4
Anupam Sarma, Debabrata Barmon, J.D. Sharma, Amal Chandra Kataki, Chidananda Bhuyan
DOI:
http://dx.doi.org/10.6000/1929-2279.2012.01.01.01

 

Extramedullary Plasmacytoma of the Lung – Rather a Disseminated than a Localized Disease? – A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread - Pages 5-9
Lisa Billecke, Eva Maria Murga Penas, Jozef Zustin, Thorsten Derlin, Carsten Bokemeyer and Georgia Schilling
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.02

 

Topical Treatment of Skin Squamous Cell Carcinoma with Potassium Dobesilate Cream
- Pages 10-13
Pedro Cuevas, Javier Angulo, Adrián Cuevas-Bourdier and Guillermo Giménez-Gallego
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.03

 

Moving EGFR Targeted Therapy into the Induction Phase of the Management of Squamous Cell Carcinoma of the Head and Neck - Pages 14-21
Belisario A. Arango, Bertha E. Sanchez, Matthew C. Abramowitz and Edgardo S. Santos
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.04

 

Does Tumour Biological Behaviour Influence Prognosis More than Diagnostic Delay in Oral Cancer? - Pages 22-27
Juan Manuel Seoane-Romero, Pablo Ignacio Varela-Centelles, Pedro Diz-Dios, Isabel Ramos-Barbosa, Javier Fernández Feijoo and Juan Seoane
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.05

 

Brain Tumor Stem Cells and Immunotherapy - Pages 28-38
Isako Saga and Masahiro Toda
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.06

 

Collision Primary Tumor of the Endometrium: Large Cell Neuroendocrine Carcinoma and Endometrioid Adenocarcinoma - Pages 39-43
Wyatt Unger, Qian Tang, Danielle Summers and Wenxin Zheng
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.07

 

Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients - Pages 44-48
Julia E. Stokes, Michael S. Bobola, Marc C. Chamberlain and John R. Silber
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.08

 

PAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in Alveolar Rhabdomyosarcoma Cells - Pages 49-56
Lingling Liu and Taosheng Chen

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.09

 

Transcriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer - Pages 57-68
Kathryn A. Bailey, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C. Wolf, Stephen W. Edwards and Rebecca C. Fry

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.10

 

Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist - Pages 69-77
Guanghui Yang, Honglu Zhang and Glenn D. Prestwich

DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.11

 

TAT-Mediated Delivery of p27 in Tumor Cell Lines as a Potential Therapeutic Peptide
- Pages 78-86
Ana-Matea Mikecin and Mira Grdisa
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.12

 

Mobile Phone Based Healthcare Platform for Assisting Lung Cancer Prevention - Pages 87-93
Jun Yang, Bowei Chen and Jing Liu
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.13

 

Present and Emerging Targeted Therapy for Metastatic Breast Cancer - Pages 94-101
Vito Lorusso, Ilaria Marech, Marianna Giampaglia, Antonio Gnoni, Andrea Tinelli and Vincenzo Emanuele Chiuri
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.14

 

EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence - Pages 102-107
Kenichi Suda, Simon Ito, Hiroshi Mizuuchi, Yoshihiko Maehara, Yasushi Yatabe and Tetsuya Mitsudomi
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.15

 

Treatment of Chemotherapy – Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help - Pages 108-113
Krzysztof Brzeziński
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.16

 

High-Expression of PTEN and an Absence of PCNA in Osteoclast-Like Multinucleated Giant Cells of Giant Cell Tumors in Bone- Pages 114-121
Chao Lou, Rong Qiang, Hongmin Yan and Jie Li
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.17

 

Biological Efficacy of a Dendritic Cell-Based Vaccine in a Patient with Metastatic Colorectal Cancer - Pages 122-128
Mario M. Soldevilla, Susana Inogés, Ascensión López-Díaz de Cerio, Fernando Pastor, Helena Villanueva and Maurizio Bendandi
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.18

 

Strategies of Targeting Tumors and Cancers - Pages 129-152
Rajesh K. Saini, Raje Chouhan, Laxmi P. Bagri and A.K. Bajpai
DOI: http://dx.doi.org/10.6000/1929-2279.2012.01.01.19

 

Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

OUR STRENGTHS

♦  Worldwide readership
♦  High quality content
♦  Maximum visibility
♦  Efficient publishing
♦  Optional Open Access

Publish your Research

Survey

As an author what type of publishing model you prefer?

780
Open Access
493
Optional Open Access
338
Subscription based
5 Votes left